aniracetam has been researched along with Cerebral Infarction in 3 studies
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of aniracetam, a cognition enhancer, on extracellular levels of glutamate (Glu), gamma-aminobutyric acid (GABA) and nitric oxide metabolites (NOx) were examined in the prefrontal cortex (PFC) and the basolateral amygdala (AMG) in stroke-prone spontaneously hypertensive rats (SHRSP) using in vivo microdialysis." | 7.71 | Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. ( Matsumoto, M; Nakamura, K; Ohashi, S; Saito, H; Togashi, H; Ueno, K; Yoshioka, M, 2002) |
| "Aniracetam has been used to improve the mental condition of patients with cerebrovascular disease." | 5.31 | Effects of aniracetam on bladder overactivity in rats with cerebral infarction. ( Kodama, K; Komatsu, K; Nagasaka, Y; Nakada, Y; Namiki, M; Niikura, S; Yokoyama, O; Yotsuyanagi, S, 2000) |
| "The effects of aniracetam, a cognition enhancer, on extracellular levels of glutamate (Glu), gamma-aminobutyric acid (GABA) and nitric oxide metabolites (NOx) were examined in the prefrontal cortex (PFC) and the basolateral amygdala (AMG) in stroke-prone spontaneously hypertensive rats (SHRSP) using in vivo microdialysis." | 3.71 | Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. ( Matsumoto, M; Nakamura, K; Ohashi, S; Saito, H; Togashi, H; Ueno, K; Yoshioka, M, 2002) |
| "Aniracetam has been used to improve the mental condition of patients with cerebrovascular disease." | 1.31 | Effects of aniracetam on bladder overactivity in rats with cerebral infarction. ( Kodama, K; Komatsu, K; Nagasaka, Y; Nakada, Y; Namiki, M; Niikura, S; Yokoyama, O; Yotsuyanagi, S, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katsunuma, H | 1 |
| Shimizu, T | 1 |
| Ogawa, K | 1 |
| Kubo, H | 1 |
| Ishida, H | 1 |
| Yoshihama, A | 1 |
| Nakada, Y | 1 |
| Yokoyama, O | 1 |
| Komatsu, K | 1 |
| Kodama, K | 1 |
| Yotsuyanagi, S | 1 |
| Niikura, S | 1 |
| Nagasaka, Y | 1 |
| Namiki, M | 1 |
| Togashi, H | 1 |
| Nakamura, K | 1 |
| Matsumoto, M | 1 |
| Ueno, K | 1 |
| Ohashi, S | 1 |
| Saito, H | 1 |
| Yoshioka, M | 1 |
1 review available for aniracetam and Cerebral Infarction
| Article | Year |
|---|---|
Treatment of insomnia by concomitant therapy with Zopiclone and Aniracetam in patients with cerebral infarction, cerebroatrophy, Alzheimer's disease and Parkinson's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Azabicyclo Compounds; Cerebral Cortex; Cerebral Infarction; Drug T | 1998 |
2 other studies available for aniracetam and Cerebral Infarction
| Article | Year |
|---|---|
Effects of aniracetam on bladder overactivity in rats with cerebral infarction.
Topics: Animals; Atropine; Cerebral Infarction; Dose-Response Relationship, Drug; Female; Injections, Intrav | 2000 |
Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats.
Topics: Amino Acids; Amygdala; Animals; Cerebral Infarction; Extracellular Space; gamma-Aminobutyric Acid; G | 2002 |